Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911143582> ?p ?o ?g. }
- W2911143582 endingPage "66" @default.
- W2911143582 startingPage "58" @default.
- W2911143582 abstract "Acute inflammation induces sensitization of nociceptive neurons and triggers the accumulation of calcium permeable (CP) α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) in the dorsal horn of the spinal cord. This coincides with behavioral signs of acute inflammatory pain, but whether CP-AMPARs contribute to chronic pain remains unclear. To evaluate this question, we first constructed current-voltage (IV) curves of C-fiber stimulus-evoked, AMPAR-mediated EPSCs in lamina II to test for inward rectification, a key characteristic of CP-AMPARs. We found that the intraplantar injection of complete Freund's adjuvant (CFA) induced an inward rectification at 3 d that persisted to 21 d after injury. Furthermore, the CP- AMPAR antagonist IEM-1460 (50 μM) inhibited AMPAR-evoked Ca2+ transients 21d after injury but had no effect in uninflamed mice. We then used a model of long-lasting vulnerability for chronic pain that is determined by the balance between latent central sensitization (LCS) and mu opioid receptor constitutive activity (MORCA). When administered 21 d after the intraplantar injection of CFA, intrathecal administration of the MORCA inverse agonist naltrexone (NTX, 1 μg, i.t.) reinstated mechanical hypersensitivity, and superfusion of spinal cord slices with NTX (10 μM) increased the peak amplitude of AMPAR-evoked Ca2+ transients in lamina II neurons. The CP-AMPAR antagonist naspm (0–10 nmol, i.t.) inhibited these NTX-induced increases in mechanical hypersensitivity. NTX had no effect in uninflamed mice. Subsequent western blot analysis of the postsynaptic density membrane fraction from lumbar dorsal horn revealed that CFA increased GluA1 expression at 2 d and GluA4 expression at both 2 and 21 d post-injury, indicating that not just the GluA1 subunit, but also the GluA4 subunit, contributes to the expression of CP-AMPARs and synaptic strength during hyperalgesia. GluA2 expression increased at 21 d, an unexpected result that requires further study. We conclude that after tissue injury, dorsal horn AMPARs retain a Ca2+ permeability that underlies LCS. Because of their effectiveness in reducing naltrexone-induced reinstatement of hyperalgesia and potentiation of AMPAR-evoked Ca2+ signals, CP-AMPAR inhibitors are a promising class of agents for the treatment of chronic inflammatory pain." @default.
- W2911143582 created "2019-01-25" @default.
- W2911143582 creator A5008016466 @default.
- W2911143582 creator A5018643852 @default.
- W2911143582 creator A5022117254 @default.
- W2911143582 creator A5065104284 @default.
- W2911143582 creator A5069458049 @default.
- W2911143582 creator A5083705397 @default.
- W2911143582 date "2019-04-01" @default.
- W2911143582 modified "2023-09-25" @default.
- W2911143582 title "Opioid receptors inhibit the spinal AMPA receptor Ca2+ permeability that mediates latent pain sensitization" @default.
- W2911143582 cites W1544008935 @default.
- W2911143582 cites W1965202553 @default.
- W2911143582 cites W1968137478 @default.
- W2911143582 cites W1969751124 @default.
- W2911143582 cites W1972797480 @default.
- W2911143582 cites W1973081422 @default.
- W2911143582 cites W1973966533 @default.
- W2911143582 cites W1976860452 @default.
- W2911143582 cites W1982939797 @default.
- W2911143582 cites W1983252720 @default.
- W2911143582 cites W1994778254 @default.
- W2911143582 cites W1995680954 @default.
- W2911143582 cites W1997185941 @default.
- W2911143582 cites W1997675236 @default.
- W2911143582 cites W1998878665 @default.
- W2911143582 cites W1999968276 @default.
- W2911143582 cites W2000779549 @default.
- W2911143582 cites W2006350480 @default.
- W2911143582 cites W2009886065 @default.
- W2911143582 cites W2016315625 @default.
- W2911143582 cites W2019422458 @default.
- W2911143582 cites W2021950821 @default.
- W2911143582 cites W2022957057 @default.
- W2911143582 cites W2023743123 @default.
- W2911143582 cites W2029396512 @default.
- W2911143582 cites W2038400469 @default.
- W2911143582 cites W2047615113 @default.
- W2911143582 cites W2050681657 @default.
- W2911143582 cites W2051084778 @default.
- W2911143582 cites W2057925384 @default.
- W2911143582 cites W2059117412 @default.
- W2911143582 cites W2063461600 @default.
- W2911143582 cites W2072252713 @default.
- W2911143582 cites W2075147858 @default.
- W2911143582 cites W2076808653 @default.
- W2911143582 cites W2077323366 @default.
- W2911143582 cites W2077343488 @default.
- W2911143582 cites W2078972659 @default.
- W2911143582 cites W2090068017 @default.
- W2911143582 cites W2093337999 @default.
- W2911143582 cites W2094150585 @default.
- W2911143582 cites W2109334096 @default.
- W2911143582 cites W2120208239 @default.
- W2911143582 cites W2128574573 @default.
- W2911143582 cites W2132809690 @default.
- W2911143582 cites W2137138688 @default.
- W2911143582 cites W2138499080 @default.
- W2911143582 cites W2141395118 @default.
- W2911143582 cites W2170532212 @default.
- W2911143582 cites W2172201406 @default.
- W2911143582 cites W2176291309 @default.
- W2911143582 cites W2206442434 @default.
- W2911143582 cites W2227817565 @default.
- W2911143582 cites W2288839105 @default.
- W2911143582 cites W2322205927 @default.
- W2911143582 cites W2515687644 @default.
- W2911143582 cites W2556818902 @default.
- W2911143582 cites W2588303811 @default.
- W2911143582 cites W2606320674 @default.
- W2911143582 cites W2607249536 @default.
- W2911143582 cites W2612695115 @default.
- W2911143582 cites W2751185950 @default.
- W2911143582 cites W2767890607 @default.
- W2911143582 cites W96392281 @default.
- W2911143582 doi "https://doi.org/10.1016/j.expneurol.2019.01.003" @default.
- W2911143582 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6559354" @default.
- W2911143582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30660616" @default.
- W2911143582 hasPublicationYear "2019" @default.
- W2911143582 type Work @default.
- W2911143582 sameAs 2911143582 @default.
- W2911143582 citedByCount "18" @default.
- W2911143582 countsByYear W29111435822019 @default.
- W2911143582 countsByYear W29111435822020 @default.
- W2911143582 countsByYear W29111435822021 @default.
- W2911143582 countsByYear W29111435822022 @default.
- W2911143582 countsByYear W29111435822023 @default.
- W2911143582 crossrefType "journal-article" @default.
- W2911143582 hasAuthorship W2911143582A5008016466 @default.
- W2911143582 hasAuthorship W2911143582A5018643852 @default.
- W2911143582 hasAuthorship W2911143582A5022117254 @default.
- W2911143582 hasAuthorship W2911143582A5065104284 @default.
- W2911143582 hasAuthorship W2911143582A5069458049 @default.
- W2911143582 hasAuthorship W2911143582A5083705397 @default.
- W2911143582 hasBestOaLocation W29111435822 @default.
- W2911143582 hasConcept C112592302 @default.
- W2911143582 hasConcept C118552586 @default.
- W2911143582 hasConcept C126322002 @default.